Provectus's PV-10 Phase 2 data to be presented at 7th International Melanoma Research

[News]

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 PV-10 metastatic melanoma study will be presented at the 7th International Melanoma Research Congress in Sydney, Australia, on November 4, 2010 at 4:30 p.m., as part of the 4th Interdisciplinary Melanoma & Skin Cancer Centres Meeting,

More... (http://www.news-medical.net/news/20100913/Provectuss-PV-10-Phase-2-data-to-be-presented-at-7th-International-Melanoma-Research-Congress.aspx)